Ketotifen/naphazoline

DRUG2 trials

Sponsors

Bausch & Lomb Incorporated

Conditions

Allergic Conjunctivitis

Phase 3

Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.

CompletedNCT00769886

Bausch & Lomb IncorporatedAllergic Conjunctivitis

Start: 2008-10-31End: 2009-06-30Updated: 2024-04-03

Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.

CompletedNCT00770133

Bausch & Lomb IncorporatedAllergic Conjunctivitis

Start: 2010-02-28End: 2010-06-30Updated: 2020-10-27